Skip to main content
Anatomical Therapeutic Chemical • L01EC • B-raf serine-threonine kinase (BRAF) inhibitors
L01EC01
vemurafenib
Indicated for:
melanoma
L01EC02
dabrafenib
Indicated for:
melanoma
L01EC03
encorafenib
Indicated for:
melanoma; colorectal cancer
L01EC04
tovorafenib
Indicated for:
relapsed or refractory BRAF-altered pediatric low-grade glioma